# An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

> **NCT04343768** · PHASE2 · COMPLETED · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Lopinavir / Ritonavir
- **DRUG:** Interferon Beta-1A
- **DRUG:** Interferon Beta-1B

## Key facts

- **NCT ID:** NCT04343768
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-09
- **Primary completion:** 2020-04-27
- **Final completion:** 2020-04-27
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04343768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04343768, "An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04343768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*